VCI Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Buy
29,344
+809
+3% +$94.7K 0.95% 27
2026
Q1
$3.43M Buy
28,535
+4,597
+19% +$531K 0.95% 23
2025
Q4
$2.52M Buy
23,938
+6,196
+35% +$582K 0.7% 33
2025
Q3
$1.49M Buy
17,742
+1,943
+12% +$160K 0.45% 47
2025
Q2
$1.25M Buy
15,799
+2,430
+18% +$193K 0.44% 64
2025
Q1
$1.2M Sell
13,369
-7,581
-36% -$708K 0.5% 56
2024
Q4
$2.08M Buy
20,950
+1,489
+8% +$154K 0.88% 30
2024
Q3
$2.21M Buy
19,461
+13,848
+247% +$1.65M 0.98% 28
2024
Q2
$695K Buy
5,613
+943
+20% +$121K 0.34% 71
2024
Q1
$616K Sell
4,670
-2,485
-35% -$306K 0.42% 65
2023
Q4
$780K Buy
+7,155
New +$743K 0.47% 62

Other funds holding MRK

VCI Wealth Management's MRK Position: Q2 2026 in Review

VCI Wealth Management increased its Merck (MRK) stake by 2.8% in Q2 2026, buying an estimated $94.7K and bringing the position to 29,344 shares worth $3.77M. The position accounts for 0.95% of the portfolio, ranked #27.

VCI Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • VCI Wealth Management held 29,344 shares of Merck worth $3.77M as of Q2 2026.
  • VCI Wealth Management bought 809 Merck shares in Q2 2026, an estimated $94.7K.
  • Merck made up 0.95% of VCI Wealth Management's portfolio in Q2 2026, its #27 holding.
  • VCI Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on VCI Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.